Urgent Notice to All Conference Participants

It has been brought to our attention that EHS Housing has recently been cold calling our speakers offering accommodation for a named Fusion conference. Please note that we have no association with EHS Housing and they are acting on our behalf without our permission. We strongly advise that any calls from EHS Housing are ignored or ended immediately. If you are contacted by EHS Housing, please notify us immediately.

All Fusion registration fees are inclusive of accommodation (for three fixed nights) and reservations are handled internally, entirely by Fusion Conferences. If you have any questions concerning your accommodation, please contact Fusion Conferences directly via admin@fusion-conferences.com.

Home > Past Conferences > Enabling Future Pharma

The registration process for this conference has now closed.

Registration Deadlines

Early bird – expired

Talk Submission – expired

Poster Submission – expired

Last Chance – expired

Enabling Future Pharma

Strategic Initiatives in Collaborative Innovation in Drug Discovery, Heralding the Mutually Inclusive Role of NIH, Academia, Pharma and Patient-Based organizations

09 Jul 2014 - 12 Jul 2014

Bloomingdale, Chicago, USA

Synopsis

To view a list of our current speakers, please click "read more"

Resurgence of the pharmaceutical industry to its preeminence can only be realized through Collaborative Innovation in Biomedicine. Given the complexities and the expense of pharmaceutical R&D, we can accomplish much more, in a shorter time and with less cost and duplication of effort, when the private and public sectors bring their special strengths to bear. These are challenging times, but they also offer unprecedented opportunities to form complementary and synergistic partnerships and collaborative research enterprises with an overarching goal of advancing drug discovery breakthroughs and bridge the translational gap. The focus of the conference is to:

  • showcase cutting edge research-tools, technologies, and chemical biology
  • gain perspectives on the benefits and potential issues surrounding collaborative innovation between the public and private sectors
    • learn how academia and disease foundations are becoming the driving force behind innovation
    • understand how non-profits, including patient-based organizations, could play as catalysts in meeting the needs of patients and caregivers
  • explore government initiatives that help foster cooperation between industry and academia
  • assess patient advocacy and population health management initiatives towards affordable and quality healthcare

The conference aims to bring together thought leaders and senior executives from pharma, academia, NIH, diseases foundations and patient advocacy groups to critically assess current operational models, and engage in panel discussions spanning a broad range of scientific and business initiatives.

 

 

Sponsors

Sponsors

Programme

10:00 - 19:00 DAY ONE, Wednesday 09 July , Session One Pre-competitive Collaborative Innovation Strategies
10:15 - 11:15 John Mckew COLLABORATIVE TRANSLATION AT NCATS
11:15 - 11:45 TC Chung COLLABORATIVE MODELS AT SANFORD|BURNHAM FOR ACADEMIC DRUG DISCOVERY TO LEVERAGE GOVERNMENT FUNDING WITH THE MAYO CLINIC AND THE FLORIDA TRANSLATIONAL RESEARCH PROGRAMS AND APPLYING TO RARE & NEGLECTED DISEASES
11:45 - 12:15 Mark Suto THE INTERFACE BETWEEN ACADEMIA AND INDUSTRY- DRUG DISCOVERY AT SOUTHERN RESEARCH INSTITUTE.
12:15 - 12:45 Larry Sklar PARTNERSHIPS FOR TECHNOLOGICAL INNOVATION, DRUG DISCOVERY, CLINICAL TRANSLATION AND COMMERCIALIZATION AT THE UNIVERSITY OF NEW MEXICO CENTER FOR MOLECULAR DISCOVERY
12:45 - 13:15 Chris Paschall ACADEMIC-PHARMA INDUSTRY PARTNERSHIPS: A FORCED MARRIAGE OF CONVENIENCE?
13:15 - 13:45 DISCUSSION PANEL
13:45 - 16:30 Lunch and Free Time
16:30 - 18:00 DAY ONE SESSION TWO Voluntary Health Organization- Operational Models
16:30 - 17:15 John Hardin THE ROLE OF A PATIENT BASED ORGANIZATION IN ADVANCING NEW TREATMENTS FOR OSTEOARTHRITIS.
17:15 - 18:00 Bruce Bloom CREATING MEDICAL SOLUTIONS THROUGH SOCIAL FINANCING
18:00 - 18:30 Refreshments
18:30 - 19:00 Tanya Parish COLLABORATIVE APPROACHES TO SOLVING MAJOR GLOBAL HEALTH PROBLEMS: TUBERCULOSIS DRUG DISCOVERY AS A PARADIGM
19:00 - 19:30 DISCUSSION PANEL
08:30 - 12:30 DAY TWO, Thursday 10th July, Session Three Academic Screening Centers Come of Age
08:30 - 09:15 Hakim Djaballah CHEMICAL & RNAI SCREENING AT MSKCC: A COLLABORATIVE PLATFORM TO DISCOVER & REPURPOSE DRUGS TO FIGHT DISEASE
09:15 - 09:45 Larry Sklar SCALABLE APPROACHES FOR GPCR SMALL MOLECULE DISCOVERY AND PRECISION MEDICINE
09:45 - 10:15 Martha Larsen DRUG DISCOVERY AT THE UNIVERSITY OF MICHIGAN
10:15 - 10:45 Refreshments
10:45 - 11:15 J. Fraser Glickman DRUG DISCOVERY INITIATIVES, INFRASTRUCTURE AND FUNDING AT THE ROCKEFELLER UNIVERSITY
11:15 - 11:45 Vadim Gurvich ITDD: THE ENGINE OF DRUG DISCOVERY AND DEVELOPMENT AT THE UNIVERSITY OF MINNESOTA
11:45 - 12:15 Anuradha Roy DRUG DISCOVERY AND HIGH THROUGHPUT SCREENING AT THE UNIVERSITY OF KANSAS
12:15 - 12:45 DISCUSSION PANEL
12:45 - 14:00 Lunch
14:00 - 16:30 Free Time
16:30 - 20:30 DAY TWO SESSION FOUR Cutting Edge Research-tools, Technologies for Chemical Biology
16:30 - 17:00 Said Goueli ADP GLOTM: A ONE PLATFORM IDEAL FOR ASSAY DEVELOPMENT, SCREENING AND PROFILING OF ALL PHOSPHOTRANSFERASES
17:00 - 17:30 Roger Bosse ALPHAPLEX: A NOVEL ULTRA-SENSITIVE HOMOGENEOUS MULTIPLEX IMMUNOASSAY PLATFORM
17:30 - 18:00 Joe Olechno DRUG DISCOVERY CAN BE PROFOUNDLY AFFECTED BY DILUTION TECHNIQUES
18:00 - 18:30 Refreshments
18:30 - 19:00 Kevin Lustig CREATION OF A NEW RESEARCH ENGINE FOR PHARMACEUTICAL DRUG DISCOVERY
19:00 - 19:30 Indu Javeri NANOLIPOSOMES: ROLE IN THE EVOLUTION OF NANOMEDICINE
19:30 - 20:00 Matthew Segall ADDRESSING TOXICITY RISK WHEN DESIGNING AND SELECTING COMPOUNDS IN EARLY DRUG DISCOVERY
20:00 - 20:30 Panel Discussion
08:30 - 12:30 DAY THREE, Friday 11th July, Session Five Research Advocacy and Population Health Management
08:30 - 09:15 Sreekanth Chaguturu HOW PHYSICIANS ARE RE-EXAMINING MEDICAL AND DRUG COSTS IN THE POST-REFORM WORLD: THE PARTNERS HEALTHCARE STORY
09:15 - 09:45 Lynn Matrisian A PATIENT-CENTERED APPROACH TO DOUBLING SURVIVAL FROM PANCREATIC CANCER
09:45 - 10:15 Deborah Collyar HOW DO YOU LABEL SUCCESS: FDA APPROVAL OR MARKET ACCEPTANCE?
10:15 - 10:45 Refreshments
10:45 - 11:15 Stephen Goldner SUCCESS STRATEGY TO ACCELERATE ENROLLING PATIENTS INTO CLINICAL TRIALS
11:15 - 11:45 Panel Discussion
11:45 - 13:30 Lunch
13:30 - 16:30 Free Time
16:30 - 20:00 DAY THREE, SESSION SIX Drugging the undruggable, Chemical Keys for Life's Locks
16:30 - 17:15 Rathnam Chaguturu CHEMICAL KEYS FOR LIFE'S LOCKS: AN IMPASSIONED PLEA FOR SMARTER CHEMICAL LIBRARIES TO IMPROVE DRUG LEAD FINDING
17:15 - 17:45 Barry Bunin THE COLLABORATIVE DRUG DISCOVERY PARADIGM: MODERN DRUG RESEARCH INFORMATICS APPLIED TO CNS, INFECTIOUS, NEGLECTED, RARE, AND COMMERCIAL DISEASE APPLICATIONS
17:45 - 18:15 Harish Pant A NOVEL TRANSLATIONAL APPROACH TO NEURODEGENERATIVE DISEASES; PEPTIDES DERIVED FROM THE ACTIVATOR OF A NEURONAL CYCLIN DEPENDENT LIKE KINASE (CDK5) PREVENT THE PHENOTYPES OF ALZHEIMER'S AND OTHER NEURODEGENERATIVE DISEASE MODEL MICE.
18:15 - 18:45 Refreshments
18:45 - 19:15 Haian Fu TARGETING PROTEIN-PROTEIN INTERACTIONS FOR CHEMICAL BIOLOGY AND TRANSLATIONAL RESEARCH
19:15 - 19:45 Mahabir Gupta MEDICINAL PLANTS AND NATURAL PRODUCTS FROM LATIN AMERICA – SUBJECTS OF INTERNATIONAL SCIENTIFIC EXCHANGES
19:45 - 20:15 Panel Discussion
21:00 - 00:00 ** Gala Dinner **
08:30 - 10:30 DAY FOUR, Saturday 12th July, Session Seven Data Irreproducibility and Scientific Paradigm
08:30 - 08:50 Rathnam Chaguturu SCIENTIFIC MISCONDUCT IN BIOMEDICAL SCIENCES
08:50 - 09:10 Hakim Djaballah TEN YEARS OF RNAI SCREENING: TOO MUCH HAY & VERY FEW NEEDLES?
09:10 - 10:00 DISCUSSION PANEL
10:00 - 10:30 Refreshments
10:30 - 13:00 DAY FOUR SESSION EIGHT Reinventing the Drug Discovery Paradigm
10:30 - 11:15 Ibis Sanchez Serrano COPTIMIZING THE CORE MODEL’S “PERIPHERY” ROLE IN DRUG DISCOVERY AND DEVELOPMENT
11:15 - 11:45 Jeanne Farrell ACADEMIC TECHNOLOGY TRANSFER OFFICES: FACILITATORS OF FEULING THE PHARMA PIPELINE?
11:45 - 12:15 Bruce Bloom CREATING MEDICAL SOLUTIONS THROUGH SOCIAL FINANCING
12:15 - 12:45 Meg Mangin OFF-LABEL USE OF OLMESARTAN MEDOXOMIL RESOLVES SYMPTOMS OF AUTOIMMUNE AND INFLAMMATORY DISEASES
12:45 - 13:00 DISCUSSION PANEL
13:00 - 13:15 Closing Remarks & Farewell & Goodbye

Speakers

Plenary Speakers

  • Dr. Sree Chaguturu
    Vice President, Population Health Management, Partners HealthCare
  • Dr Hakim Djaballah
    Director, HTS Core Facility, MSKCC
  • Mr Ibis Sanchez-Serrano
    President, The Core Model Corporation
  • Ms. Deborah Collyar
    President, Patient Advocates In Research (PAIR)
  • Dr. Bruce Bloom
    President, Cures Within Reach
  • Dr John McKew
    Acting Scientific Director, Division of Pre-Clinical Innovation, National Center of Advancing Translational Sciences (NCATS), National Institutes of Health

Invited Speakers

  • Dr. Chris Paschall
    Licensing Manager, University of Virginia Licensing & Ventures Group
  • Dr. J. Fraser Glickman
    Director, The Rockefeller University
  • Dr. Thomas D.Y. (TC) Chung
    Director Outreach, Alliances and Partnerships, Sanford-Burnham Medical Research Institute (Prebys Center)
  • President & CEO Indu Javeri
    President & CEO, CuriRx Inc
  • Dr. Timothy Grese
    Chief Scientific Officer, Lead Generation and External Innovation, Eli Lilly
  • Prof. Tanya Parish
    VP, Drug Discovery, IDRI
  • Dr. Matthew Segall
    CEO, Optibrium Ltd
  • Director, UNM CMD Larry Sklar
    Professor, University of New Mexico
  • Dr. Vadim Gurvich
    Associate Director, Institute for Therapeutics Discovery & Development, University of Minnesota
  • Dr. Barry Bunin
    CEO, Collaborative Drug Discovery
  • Dr. Mark Suto
    Vice President Drug Discovery Division, Southern Research Insitute
  • Ms Renee Nicholas
    Director, Corporate Engagement, LIVESTRONG Foundation
  • Mr. Stephen Goldner
    Chief Executive Officer, CureLauncher, Inc.
  • Dr. Jeanne Farrell
    Business Development Director, Icahn School of Medicine at Mount Sinai
  • Dr. Kevin Lustig
    CEO, Assay Depot
  • Ms. Martha Larsen
    HTS Director, Center for Chemical Genomics, University of Michigan
  • Dr. Joe Olechno
    Senior Research Fellow, Labcyte
  • Professor Mahabir Gupta
    Professor and Director, CYTED
  • Dr Anuradha Roy
    Director, University of Kansas
  • Dr Roger Bosse
    Senior Global Product Leader, PerkinElmer Life Sciences & Technology
  • Dr. Said Goueli
    Senior Research Fellow, Promega Corp.
  • Dr. Lynn Matrisian
    Vice President, Scientific & Medical Affairs, Pancreatic Cancer Action Network
  • Dr Haian Fu
    Professor of Pharmacology and Hematology & Medical Oncology, Emory Chemical Biology Discovery Center
  • Dr Harish C. Pant
    Senior Investigator, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)

Feedback

Sign In

Your feedback has been received.

Cant see images? See gallery on Flickr